Specific Inhibitory Effects of Hybrid Liposomes on the Growth of Various Tumor Cells
Specific Inhibitory Effects of Hybrid Liposomes on the Growth of Various Tumor Cells
批准号:
10680811
负责人:
MATSUMOTO Yoko
金额:
$1.79万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
1.混合脂质体对肿瘤细胞在体外生长的抑制作用:混合脂质体由脂质体组成的一种不同的头部组(双离子L-α-二聚氰酸酯胆碱(DMPC)、阴离子L α-二聚氰酸酯glycerol (DMPG)和cationic 1),2-dimyristoyl-3-trimethylammonium propane (DMTAP)和polyoxyethylene (10)十二烷基醚(C-D212-D2(EO)-D210-D2) on the growth of tumor cells (human lung carcinoma (RERF-LC-OK)、human hepatoma (Hep-G2)、human stomach tumor (GT3TKB) in vitro were examined。It is attractive that the highly specific inhibitory effect of the hybrid liposomes composed of DMPG/10 mol % (C-D212-D2(EO)-D210-D2) On the growth of RERF-LC-OK and GT3TKB was obtained without any antitumor drugs.2。Apoptosis Hybrid脂质体的诱导我们研究了由dimyristoylphosphatidylcholine和polyoxyethylenealkyl ether进行的抑制作用,使肿瘤细胞的生长与Apoptosis有关。通过HL-60细胞中混合脂质体的凋亡定义,对琼脂糖凝胶电泳的基础进行了验证,DNA和流式细胞分析用前列腺碘化物固定方法进行了分析。一个荧光显微图使用荧光素异硫氰酸酯作为荧光探测显示,混合脂质体应该与肿瘤细胞膜一起失效。在融合后,混合脂质体的累积被揭示为肿瘤细胞膜的基础。用混合脂质体的黑色素瘤小鼠小鼠模型的化学疗法已由Lewis lung carcinoma细胞的内部炎症研究所证实。可显著延长的存活率(480%)被管理成老鼠的混合脂质体。以下结果建议是,混合储存液体应该对癌症的治疗产生影响。长期而言,混合脂质体没有毒性,在正常老鼠体内发现了没有副作用的情况。
英文摘要
1. Inhibitory Effects of Hybrid Liposomes on the Growth of tumor Cells in vitroThe inhibitory effects of hybrid liposomes composed of lipids having a variety of head groups (zwitterionic L-α-dimyristoylphosphatidylcholine (DMPC), anionic L α-dimyristoylphosphatidyl glycerol (DMPG) and cationic 1, 2-dimyristoyl-3-trimethylammonium propane (DMTAP)) and polyoxyethylene (10) dodecyl ether (CィイD212ィエD2(EO)ィイD210ィエD2) on the growth of tumor cells (human lung carcinoma (RERF-LC-OK), human hepatoma (Hep-G2), human stomach tumor (GT3TKB)) in vitro were examined. It is attractive that the highly specific inhibitory effect of the hybrid liposomes composed of DMPG/10mol% (CィイD212ィエD2(EO)ィイD210ィエD2) On the growth of RERF-LC-OK and GT3TKB was obtained without any antitumor drugs.2. Induction of Apoptosis Hybrid LiposomesWe examined antitumor mechanism of the hybrid liposomes composed of dimyristoylphosphatidylcholine and polyoxyethylenealkyl ether having inhibitory action toward the growth of tumor cells related to apoptosis. The induction of apoptosis by the hybrid liposomes in HL-60 cells was verified on the basis of agarose gel electrophoresis of DNA and flow cytometry analysis with the propidium iodide staining method. A fluorescence micrograph taken using fluorescein isothiocyanate as a fluorescence probe showed that the hybrid liposomes should fuse with the tumor cell membrane. After fusion, accumulation of the hybrid liposomes to tumor cell membrane was revealed on the basis of DNA analysis.3. Chemotherapy with Hybrid Liposomes for MelanomatosisA mouse model of lung carcinoma was established by intraperitoneal inoculate of Lewis lung carcinoma cells. The remarkably prolonged survival (480%) was attained by administering the hybrid liposomes to mice. This result suggests that the hybrid liposomes should be effective for the treatment of cancers. Furthermore, no toxicity of the hybrid liposomes was obtained in normal rats in vivo with no side effects.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
松本陽子: "温度感受性ハイブリット型リポソームの創製と薬物送達システムへの応用"熊本工業大学研究報告. 24・1. 107-113 (1999)
松本洋子:“温度敏感的混合脂质体的创建及其在药物递送系统中的应用”熊本工业大学研究报告24・1(1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Akihiro Kanno: "Chemotherapy with Hybrid Liposomes for Melanomatosis"Biological&Pharmaceutical Bulletin. 22・9. 1013-1014 (1999)
Akihiro Kanno:“混合脂质体化疗治疗黑色素瘤”生物与药物通报 22・9(1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
金納 明宏: "肺癌モデルマウスに対するハイブリッド型リポソームの治療効果"Drug Delivery System. 14. 37-42 (1999)
Akihiro Kanano:“混合脂质体对肺癌模型小鼠的治疗效果”药物输送系统。14. 37-42 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Akihiro Kanno: "Therapeutic Effects of Hybrid Liposomes on mice Model of Lung Carcinoma"Drug Delivery System. 14. 37-42 (1999)
Akihiro Kanno:“混合脂质体对小鼠肺癌模型的治疗效果”药物输送系统。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoko Matsumoto: "Intracellular Responses of Hybrid Liposomes against Leukemia Cells Related to Apoptosis with Antitumor Activity"Chemistry Letters. 1999. 53-54 (1999)
Yoko Matsumoto:“混合脂质体对白血病细胞的细胞内反应,与具有抗肿瘤活性的细胞凋亡相关”化学快报。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 22 条
Therapeutic effects of hybrid liposomes against rheumatoid arthritis
-
批准号:15K12527
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2015
-
负责人:MATSUMOTO Yoko
-
依托单位:
Development of research with liposomes toward clinical application for cancer and AIDS
-
批准号:23300173
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2011
-
负责人:MATSUMOTO Yoko
-
依托单位:
Application and evaluation of proteasome Inhibitor MG132-loaded polymeric micelle using in vivo imaging technique
-
批准号:23791812
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.66万
-
财政年份:2011
-
负责人:MATSUMOTO Yoko
-
依托单位:
Research of Multi-ethnic Coexistence Using Social Simulation as Post-colonial Dialogue
-
批准号:22402048
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.23万
-
财政年份:2010
-
负责人:MATSUMOTO Yoko
-
依托单位:
Enhanced Antitumor Activity of Proteasome Inhibitor MG132-loaded Polymeric Micelle Drug Carriers, Analyzed by In Vivo Real-Time Confocal Microangiography
-
批准号:21791542
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2009
-
负责人:MATSUMOTO Yoko
-
依托单位:
Control of Interface in Cancer Cell Membranes and Inhibitory Effects of Three-component Hybrid Liposomes Including Sugar Surfactant
-
批准号:20560732
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:MATSUMOTO Yoko
-
依托单位:
Inhibitory Effects of Hybrid Liposomes on the Growth of Tumor Cells along with Apoptosis Through the Activation of Caspases.
-
批准号:17500323
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2005
-
负责人:MATSUMOTO Yoko
-
依托单位:
Chemotherapy with Hybrid Liposomes Along with Induction of Apoptosis
-
批准号:15500335
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2003
-
负责人:MATSUMOTO Yoko
-
依托单位:
Specific Hybrid Liposomes with Markedly Enhanced Inhibitory Effects on the Growth of Tumor Cells
-
批准号:07808101
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1995
-
负责人:MATSUMOTO Yoko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
基于Notch-1介导miR-200家族调控上皮间质转化对绒癌耐药机制的研究
-
批准号:81972428
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:安瑞芳
-
依托单位:
地塞米松诱导的人卵巢癌对化疗药物耐受及其机制的研究
-
批准号:81172471
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2011
-
负责人:陈玉霞
-
依托单位:
维生素B3促进化疗导致粒细胞减少症的中性粒细胞生成功能及作用机制研究
-
批准号:81060045
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:蓝丹
-
依托单位:
番荔枝内酯抗肿瘤作用及调节肿瘤耐药分子调控网络研究
-
批准号:30973854
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:欧阳学农
-
依托单位:
应用蛋白敲除技术降解ErbB家族的抗乳腺癌作用及其机制研究
-
批准号:30901754
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:李慧
-
依托单位:
卵巢癌肿瘤干细胞特异性microRNA分子靶点调控的研究
-
批准号:30873011
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2008
-
负责人:沈铿
-
依托单位:
巨噬细胞诱导的大肠癌靶向治疗实验研究
-
批准号:30471998
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2004
-
负责人:张继民
-
依托单位: